Schizoaffective Disorders Completed Phase 4 Trials for Haloperidol (DB00502)

Also known as: Schizoaffective disorder / Schizophrenia schizoaffective / Schizoaffective psychosis / Schizo-affective type schizophrenia

IndicationStatusPhase
DBCOND0033299 (Schizoaffective Disorders)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02307396Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic PatientsTreatment
NCT00007774To Determine if Olanzapine is More Cost Effective Than Haloperidol for the Treatment of Schizophrenia
NCT00253110A Comparison of Risperidone With Haloperidol in Patients With Schizophrenia and Schizoaffective DisorderTreatment
NCT01136772A Comparison of Long-acting Injectable Medications for SchizophreniaTreatment
NCT02199743Lurasidone Effects on Tissue Glutamate in SchizophreniaTreatment